Targeting visceral adiposity with pharmacotherapy

被引：3

作者：

Gadde, Kishore M. ^{[1
]}

Heymsfield, Steven B. ^{[1
]}

机构：

[1] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA

来源：

LANCET DIABETES & ENDOCRINOLOGY | 2021年 / 9卷 / 09期

关键词：

D O I：

10.1016/S2213-8587(21)00204-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：551 / 552

页数：2

共 7 条

[1] Allometric relationship between changes of visceral fat and total fat mass [J].

Hallgreen, C. E. ;

Hall, K. D. .

INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (05) :845-852

[2] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes [J].

Kalyani, Rita R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13) :1248-1260

[3] Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial [J].

Neeland, Ian J. ;

Marso, Steven P. ;

Ayers, Colby R. ;

Lewis, Bienka ;

Oslica, Robert ;

Francis, Wynona ;

Rodder, Susan ;

Pandey, Ambarish ;

Joshi, Parag H. .

LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (09) :595-605

[4] Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement [J].

Neeland, Ian J. ;

Ross, Robert ;

Despres, Jean-Pierre ;

Matsuzawa, Yuji ;

Yamashita, Shizuya ;

Shai, Iris ;

Seidell, Jaap ;

Magni, Paolo ;

Santos, Raul D. ;

Arsenault, Benoit ;

Cuevas, Ada ;

Hu, Frank B. ;

Griffin, Bruce ;

Zainbon, Alberto ;

Barter, Philip ;

Fruchart, Jean-Charles ;

Eckel, Robert H. .

LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (09) :715-725

[5] Obesity Phenotypes, Diabetes, and Cardiovascular Diseases [J].

Piche, Marie-Eve ;

Tchernof, Andre ;

Despres, Jean-Pierre .

CIRCULATION RESEARCH, 2020, 126 (11) :1477-1500

[6] Visceral adipose tissue: a critical review of intervention strategies [J].

Smith, SR ;

Zachwieja, JJ .

INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (04) :329-335

[7]

West J, 2017, MAGNETOM FLASH, V69, P65

← 1 →